We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SF:NYSEStifel Financial Corporation Analysis

Data as of 2026-05-26 - not real-time

$72.59

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Stifel Financial (SF) is trading at roughly $72.6, well below its 20‑day and 50‑day simple moving averages of about $75.6 and $75.4, indicating short‑term price weakness. The 14‑day RSI sits near 37, suggesting the stock is approaching oversold territory. However, the MACD remains in a bearish configuration, and the histogram is negative, reinforcing a cautious near‑term bias. Volume has been trending upward, providing liquidity support as the price hovers just above the identified support level of $71.5. The broader market sentiment is extremely bullish, as reflected by a Fear & Greed Index of “Extreme Greed,” which could pressure risk assets. Despite these technical headwinds, the stock’s beta of roughly 1.2 points to higher sensitivity to market moves, amplifying potential upside if sentiment shifts.
Fundamentally, Stifel delivers robust profitability with a gross margin above 95% and an operating margin of 21.6%. Revenue grew 14.3% year‑over‑year to $5.67 billion, and earnings per share are projected to rise from $5.13 trailing to $7.00 forward. The company’s balance sheet is strong, featuring ample cash of $5.76 billion versus $2.49 billion of debt and a modest payout ratio of 24.5%. A dividend yield of 1.78% coupled with a low payout ratio underscores dividend sustainability. Recent material news highlights the launch of a Project Finance platform and a solid quarterly revenue beat, signaling strategic expansion into energy and deep‑tech financing. With a DCF‑derived fair value near $127 and analyst consensus targeting $87.5‑$87.75, the stock appears substantially undervalued, supporting a longer‑term buy case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below short‑term moving averages
  • Bearish MACD histogram
  • Increasing volume near support

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation vs DCF and analyst targets
  • Strong revenue growth and profit margins
  • Strategic expansion through new Project Finance platform

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Robust balance sheet and cash generation
  • Consistent profitability and ROE

Key Metrics & Analysis

Financial Health

Revenue Growth14.30%
Profit Margin15.56%
P/E Ratio14.2
ROE15.31%
ROA2.12%
Debt/Equity41.53
P/B Ratio2.1
Op. Cash Flow$985.7M
Industry P/E16.8

Technical Analysis

TrendNeutral
RSI37.5
Support$71.49
Resistance$79.12
MA 20$75.64
MA 50$75.35
MA 200$78.42
MACDBearish
VolumeIncreasing
Fear & Greed Index91.55

Valuation

Fair Value$127.48
Target Price$87.75
Upside/Downside20.88%
GradeUndervalued
TypeBlend
Dividend Yield1.78%

Risk Assessment

Beta1.20
Volatility28.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.